Cardamine: In my defense, I didn't "go over the company's head". The Recover TLC Project solicited input from various interested parties and that included the public at large. At the time I responded I had not heard anything that the company had applied or was intending to do so. So I, and I think at least one other member of this MB, took it upon ourselves to make sure that Leronlimab was among the treatments submitted.

My recent interaction with the Project was initiated by them, not me. I merely responded when they emailed me. I would not have done so if there had been any messaging by CYDY asking us not to. That only came afterwards. Ganesha